Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin vs erythromycin in PPROM for chorioamnionitis and latency
IRCT20240513061769N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Rupture of amniotic membranes (PROM) and intraamniotic infection (IAI) comparing Azithromycin with Erythromycin (2 arms). Primary endpoints: Incidence of clinical chorioamnionitis and Latency period to termination of pregnancy. Started May 2024; status: completed.
02
Drugs
azithromycinerythromycin
03
Conditions
Rupture of amniotic membranes (PROM)intraamniotic infection (IAI)
Beyond the preview
Go deeper on IRCT20240513061769N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240513061769N1.